Gates Ventures
Matthew Clement currently serves as the Director of Partnerships & Scientific Strategy at the Alzheimer's Disease Data Initiative and as the Director of Health & Life Sciences at Gates Ventures, positions held since April 2021. Prior to this, Matthew was with Gates Ventures as an Associate Director and Senior Program Manager from January 2019 to September 2020. Matthew's career also includes experience as an Associate Consultant at C2R Corporation from December 2013 to December 2018 and as an Associate at Booz Allen Hamilton from March 2008 to December 2013. Matthew holds a Ph.D. in Biochemistry & Molecular Biology from UCLA and a B.A. in Chemistry from Macalester College.
This person is not in any teams
This person is not in any offices
Gates Ventures
2 followers
Gates Notes is a stealth company started by Bill Gates in 2008. It is purported to be both a "think tank" and public holding company, focusing on scientific and technological innovation and services, particularly as they pertain to industry and global society.